Condensed Consolidated Statements of Operations - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
|||||
| Revenue: | ||||||||
| Revenue | $ 1,217,643 | $ 1,167,125 | $ 2,417,297 | $ 2,312,409 | ||||
| Net investment income | 282,169 | 285,636 | 562,783 | 568,214 | ||||
| Realized gains (losses) | (18,574) | (12,589) | (18,489) | (24,388) | ||||
| Other income | 49 | 74 | 118 | 150 | ||||
| Total revenue | 1,481,287 | 1,440,246 | 2,961,709 | 2,856,385 | ||||
| Benefits and expenses: | ||||||||
| Total policyholder benefits | 755,998 | 735,694 | 1,506,763 | 1,467,487 | ||||
| Amortization of deferred acquisition costs | 111,401 | 101,915 | 216,916 | 201,393 | ||||
| Commissions, premium taxes, and non-deferred acquisition costs | 157,411 | 149,802 | 321,734 | 297,912 | ||||
| Other operating expense | 108,293 | 99,108 | 217,039 | 192,322 | ||||
| Interest expense | 34,885 | 31,404 | 69,877 | 60,025 | ||||
| Total benefits and expenses | 1,167,988 | 1,117,923 | 2,332,329 | 2,219,139 | ||||
| Income before income taxes | 313,299 | 322,323 | 629,380 | 637,246 | ||||
| Income tax benefit (expense) | (60,550) | (63,968) | (122,068) | (124,674) | ||||
| Net income | $ 252,749 | $ 258,355 | $ 507,312 | $ 512,572 | ||||
| Basic net income per common share (in dollars per share) | $ 3.09 | $ 2.83 | $ 6.13 | $ 5.53 | ||||
| Diluted net income per common share (in dollars per share) | $ 3.05 | $ 2.83 | $ 6.07 | $ 5.51 | ||||
| Life Insurance | ||||||||
| Revenue: | ||||||||
| Revenue | $ 839,544 | $ 815,482 | $ 1,669,407 | $ 1,619,747 | ||||
| Benefits and expenses: | ||||||||
| Total policyholder benefits | [1] | 519,355 | 518,792 | 1,029,111 | 1,038,663 | |||
| Health Insurance | ||||||||
| Revenue: | ||||||||
| Revenue | 378,099 | 351,643 | 747,890 | 692,662 | ||||
| Benefits and expenses: | ||||||||
| Total policyholder benefits | [2] | 229,924 | 205,423 | 463,853 | 407,750 | |||
| Other | ||||||||
| Benefits and expenses: | ||||||||
| Total policyholder benefits | $ 6,719 | $ 11,479 | $ 13,799 | $ 21,074 | ||||
| ||||||||
| X | ||||||||||
- Definition Non-deferred commissions, non-deferred acquisition costs and premium taxes. No definition available.
|
| X | ||||||||||
- Definition The total amount of expense recognized during the period for future policy benefits, claims and claims adjustment costs, and for selling, general and administrative costs. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of amortization expense (reversal of expense) for deferred policy acquisition costs. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of interest expense classified as operating and nonoperating. Includes, but is not limited to, cost of borrowing accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after investment expense, of income earned from investments in securities and real estate. Includes, but is not limited to, real estate investment, policy loans, dividends, and interest. Excludes realized gain (loss) on investments. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after effects of policies assumed or ceded, of expense related to the provision for policy benefits and costs incurred. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount, after premiums ceded to other entities and premiums assumed by the entity, of premiums earned. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of realized gain (loss) on investment. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|